Clinical Trial Update: Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing psilocybin to escitalopram for major depressive disorder was completed with results posted on 2024-10-24.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)
• Psilocybin (psilocybin)

Snippet

Sponsor: Imperial College London | Conditions: Depressive Disorder, Major | Phase 2 | Status: COMPLETED | Results posted: 2024-10-24